Industry Overview

Global immunohistochemistry market was valued at USD 1.30 Bn in 2020 and is expected to grow at a CAGR of 6.8% during 2021 – 2030.

Introduction

The immunohistochemistry market Intelligence & research report cover in-depth analysis of the immunohistochemistry industry with a key focus on the global market trends, growth opportunities, market size (2020), market forecast 2030, key players Investment analysis by countries, significant industry development, etc. The report aims to provide an overview of the global immunohistochemistry market with detailed market division by type, component, by application, by source, and by regions. The immunohistochemistry market is projected to registered significant growth in specific profiled segments while other market segments are expected to witnessed declined in the revenue share over the forecasted period accounted for several influencing factors which are included in the report. The report provides industry status of the immunohistochemistry market players with market share, SWOT analysis, porter’s five force analysis, financial analysis & business strategy. The report focusses on providing data on growth opportunities, investment pockets, and regional analysis to leverage industry opportunities and gain competitive edge in the immunohistochemistry market.

Immunohistochemistry Market Covid-19 Pandemic Impact & Recovery Analysis

The report focusses extensively on covid-19 pandemic impact on immunohistochemistry market across the globe. Major industry players implemented various business strategies to recover from this global challenge which are analyze in the report. COVID-19 pandemic short -term and long-term effects on immunohistochemistry market are provided in the report.

Leading companies in the immunohistochemistry market are expected to implement key business strategies along with portfolio diversification to gain competitive edge in the market. Business strategy with pre and post covid-analysis by key competitors is provided in detail in the competitive landscape mapping segment of the immunohistochemistry market report.

Immunohistochemistry Market Segment Analysis

The report bifurcated immunohistochemistry market into key segments such as by product, by application, by end-user, and by regions, which represents global market. Market vendors across the globe in North America, Europe, Asia Pacific, Middle East & Africa, and South America are included in the report. Major factors that influence market growth in specific segment are analyze on Micro and Macro level.  The report also outlines some of the biggest development opportunities, market prediction, the introduction of the new products, and forecasting, numerous economic factors that are key in deciding the immunohistochemistry market pattern, market attractiveness and buying decisions.

Immunohistochemistry Market Regional Analysis

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and South America. Country level analysis for each region is conducted to determine leading market region and identify future growth opportunities in various regions.

Competitive Insights

Companies in the immunohistochemistry market are bifurcated into leading, emerging and prominent players for competitive landscape mapping. Prominent players in the immunohistochemistry market are investing heavily in the mergers, acquisition, partnerships and research & development of the innovative products to gain larger market share.

Key market players (Direct & Indirect Competitors)

• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• Danaher Corporation
• Perkinelmer, Inc.
• Bio-Rad Laboratories, Inc.
• Cell Signaling Technology, Inc.
• Bio SB
• Agilent Technologies, Inc.
• Abcam plc.
• Toshiba Tec Corporation

Immunohistochemistry Market Segmentation

The market intelligence & research report categorizes the immunohistochemistry market to forecast the revenues and analyze trends in each of the following subsegments:

• By Product (Revenue, USD Million, 2016 – 2030)
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining System
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological stains
    • Blocking Sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits
• By Application (Revenue, USD Million, 2016 – 2030)
  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing
• By End-User (Revenue, USD Million, 2016 – 2030)
  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others
• By Region
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America